GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Price-to-Free-Cash-Flow

Quest PharmaTech (TSXV:QPT) Price-to-Free-Cash-Flow : N/A (As of Jun. 04, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech Price-to-Free-Cash-Flow?

As of today (2024-06-04), Quest PharmaTech's share price is C$0.02. Quest PharmaTech's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Oct. 2023 was C$-0.00. Hence, Quest PharmaTech's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Quest PharmaTech's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, Quest PharmaTech's highest Price-to-Free-Cash-Flow Ratio was 10.90. The lowest was 0.00. And the median was 0.00.

TSXV:QPT's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.04
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Quest PharmaTech's Free Cash Flow per Share for the three months ended in Oct. 2023 was C$0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was C$-0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 57.10% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 52.00% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 17.90% per year.

During the past 13 years, Quest PharmaTech's highest 3-Year average Free Cash Flow per Share Growth Rate was 71.00% per year. The lowest was -43.10% per year. And the median was -2.75% per year.


Quest PharmaTech Price-to-Free-Cash-Flow Historical Data

The historical data trend for Quest PharmaTech's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech Price-to-Free-Cash-Flow Chart

Quest PharmaTech Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Quest PharmaTech Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Quest PharmaTech's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Quest PharmaTech's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest PharmaTech's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quest PharmaTech's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Quest PharmaTech's Price-to-Free-Cash-Flow falls into.



Quest PharmaTech Price-to-Free-Cash-Flow Calculation

Quest PharmaTech's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.02/-0.002
=N/A

Quest PharmaTech's Share Price of today is C$0.02.
Quest PharmaTech's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Quest PharmaTech  (TSXV:QPT) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Quest PharmaTech Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest PharmaTech (TSXV:QPT) Business Description

Traded in Other Exchanges
N/A
Address
8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4
Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.
Executives
Ragupathy Madiyalakan Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines